CLINICAL_TRIALS
trial_result
· 2021-04-20
Clinical Trial Update: A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 dose range finding study assessing Bexagliflozin tablets in adults with Type 2 diabetes mellitus; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theracos | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2021-04-20